Clinical Trial Update: Proof of Concept Study of Cognitive Improvement in Patients With Alzheimer's Disease [Phase 2]

View source ↗

Summary

Clinical trial update reports the completion of a Phase 2 proof-of-concept study evaluating cognitive improvement in patients with Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: AstraZeneca | Conditions: Alzheimer Disease | Phase 2 | Status: COMPLETED